What is your view on the potential role of immune-targeted therapies in Parkinson’s disease?
In light of phase 2 data published on azathioprine for PD by Greenland et al., PMID 41389828.
1 Answer
Mednet MemberInvited Expert
Neurology · VUMC Neurology
Answered on · Updated on
In my opinion, the role of immune-targeted therapies in Parkinson’s disease remains uncertain at this time.
While both activated microglial cells and various cytokines associated with immune activation have been detected in Parkinson’s patients, it remains unclear whether these are pathologically si...
Join for free or sign in to see the full answer